1. Design and execute formulation and process using appropriate techniques.
利用相关的知识设计筛选产品的处方工艺。
2. Communicate and work closely with other departments on project development plan, timeline, material sourcing, equipment purchasing, in-process and finished product analysis.
与其他部门良好沟通合作，跟踪项目开发计划及进度，所需原材料和设备采购计划和要求，以及中间体产品和成品的的检测分析进度。
3. Develop product manufacturing process in pilot scale and production scale.
开发中试及生产规模的生产工艺。
4. Play a major role in process scale up, validation, and technical transfer.
指导工艺放大、工艺验证和技术转移。
5. Providing written or verbal summary report on projects and activities as required
提供书面或者口头的项目进展情况。
6. Writing related documents, such as, pharmaceutical development report, batch record, study protocol and SOPs.
撰写相关文件，如：药品开发报告，批记录，研究方案和相关SOP等。

Amerigen Pharmaceuticals is a multinational company with established development and manufacturing platforms aimed at providing high-quality generic pharmaceutical products.
爱美津制药是一家集研发和制造于一体的跨国公司，旨在向美国提供高质量的仿制药品。
With pharmaceutical assets and science-based expertise in the United States and abroad, Amerigen is able to provide quality products at competitive prices along with unmatched customer service.
凭借在美国和海外的制药资产和技术专家队伍，爱美津致力于提供高品质产品、有竞争力的价格和无以匹敌的客户服务。
At the end of 2007, Amerigen has successfully completed the acquisition of an oral solid dose manufacturing facility in Suzhou Industrial Park, China and established Suzhou Amerigen Pharmaceutical Co., Ltd.
2007年底，爱美津完成了在中国苏州工业园区的口服固体制剂生产厂的收购，并成立了苏州爱美津制药有限公司。
苏州爱美津制药的里程碑如下：
2007 苏州爱美津成立
2008 首次获得美国法规文件受理
2009 首次美国食品药品监督管理局上市批准和常规检查
2010 获得美国食品药品监督管理局的批准生产大包装片剂
2012 通过中国食品药品监督管理局再次检查-新版GMP (2010版)
2013 通过美国食品药品监督管理局检查- 4个简化新药被推荐批准
2014 产品在美国市场上市, 中国市场产品恢复生产。
2015 通过美国食品药品监督管理局针对数据完整性的专项检查